{"title":"沙达方治疗蛔虫病疗效的开放标记试验研究","authors":"R. Savitha","doi":"10.20959/wjpr201711-9497","DOIUrl":null,"url":null,"abstract":"Intestinal worm infection is a common pediatric health problem causing morbidity and anguish. Sadhakuppai Chooranam is a traditional Siddha drug indicated for Kudal kirumi (Ascariasis) a common ailment among children. The current study was conducted among 40 pediatric patients (30 Out Patients and 10 In Patients) of the department of Kuzhanthai Maruthuvam at National institute of Siddha, Tambaram, Chennai. The trial drug Sadhakuppai Chooranam was given twice a day for 20 days and follow up was done once in 7 days. At each clinical visit clinical assessment was done and prognosis was noted. Laboratory investigations were done 0 day & 20th day of the trial, and the patients were followed up for another 2 months. The study data were circumspectly analyzed and are presented graphically in this work. The study results revealed that among the forty patients enrolled in the open labeled pilot study, 80% of them had very good prognosis with improvement in both clinical and laboratory parameters. Hence the trial drug Sadhakuppai Chooranam can be used clinically for the effective treatment of Kudal kirumi (Ascariasis).","PeriodicalId":23796,"journal":{"name":"World journal of pharmaceutical research","volume":"25 1","pages":"546-552"},"PeriodicalIF":0.0000,"publicationDate":"2017-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"AN OPEN LABELLED PILOT STUDY ON THE EFFICACY OF SIDDHA FORMULATION SADHAKUPPAI CHOORANAM FOR THE TREATMENT OF KUDAL KIRUMI (ASCARIASIS)\",\"authors\":\"R. Savitha\",\"doi\":\"10.20959/wjpr201711-9497\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Intestinal worm infection is a common pediatric health problem causing morbidity and anguish. Sadhakuppai Chooranam is a traditional Siddha drug indicated for Kudal kirumi (Ascariasis) a common ailment among children. The current study was conducted among 40 pediatric patients (30 Out Patients and 10 In Patients) of the department of Kuzhanthai Maruthuvam at National institute of Siddha, Tambaram, Chennai. The trial drug Sadhakuppai Chooranam was given twice a day for 20 days and follow up was done once in 7 days. At each clinical visit clinical assessment was done and prognosis was noted. Laboratory investigations were done 0 day & 20th day of the trial, and the patients were followed up for another 2 months. The study data were circumspectly analyzed and are presented graphically in this work. The study results revealed that among the forty patients enrolled in the open labeled pilot study, 80% of them had very good prognosis with improvement in both clinical and laboratory parameters. Hence the trial drug Sadhakuppai Chooranam can be used clinically for the effective treatment of Kudal kirumi (Ascariasis).\",\"PeriodicalId\":23796,\"journal\":{\"name\":\"World journal of pharmaceutical research\",\"volume\":\"25 1\",\"pages\":\"546-552\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2017-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"World journal of pharmaceutical research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.20959/wjpr201711-9497\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"World journal of pharmaceutical research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.20959/wjpr201711-9497","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
AN OPEN LABELLED PILOT STUDY ON THE EFFICACY OF SIDDHA FORMULATION SADHAKUPPAI CHOORANAM FOR THE TREATMENT OF KUDAL KIRUMI (ASCARIASIS)
Intestinal worm infection is a common pediatric health problem causing morbidity and anguish. Sadhakuppai Chooranam is a traditional Siddha drug indicated for Kudal kirumi (Ascariasis) a common ailment among children. The current study was conducted among 40 pediatric patients (30 Out Patients and 10 In Patients) of the department of Kuzhanthai Maruthuvam at National institute of Siddha, Tambaram, Chennai. The trial drug Sadhakuppai Chooranam was given twice a day for 20 days and follow up was done once in 7 days. At each clinical visit clinical assessment was done and prognosis was noted. Laboratory investigations were done 0 day & 20th day of the trial, and the patients were followed up for another 2 months. The study data were circumspectly analyzed and are presented graphically in this work. The study results revealed that among the forty patients enrolled in the open labeled pilot study, 80% of them had very good prognosis with improvement in both clinical and laboratory parameters. Hence the trial drug Sadhakuppai Chooranam can be used clinically for the effective treatment of Kudal kirumi (Ascariasis).